Differential effects of peripheral and brain tumor necrosis factor on inflammation, sickness, emotional behavior and memory in mice

Brain, Behavior, and Immunity

Volumn 58, Issue , 2016, Pages 310-326

  Klaus, Federica ^a,b   Paterna, Jean Charles ^b   Marzorati, Elisa ^a   Sigrist, Hannes ^a   Götze, Lea ^a   Schwendener, Severin ^d   Bergamini, Giorgio ^a,b   Jehli, Elisabeth ^a   Azzinnari, Damiano ^a,b   Fuertig, René ^c   Fontana, Adriano ^b   Seifritz, Erich ^a,b   Pryce, Christopher R ^a,b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d NONE

Author keywords

AAV vector; Anxiety; Anxiety disorders; Cytokine hypothesis; Depression; Fear learning memory; Reward; Sickness; TNF

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN; SACCHARIN; TUMOR NECROSIS FACTOR;

AMYGDALA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AVERSIVE BEHAVIOR; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASES; EMOTIONALITY; ESCAPE BEHAVIOR; FATIGUE; FEAR CONDITIONING TEST; HELPLESSNESS; INFLAMMATION; INVERTED TERMINAL REPEAT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR DEPRESSION; MALE; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN READING FRAME; OSMOTIC PUMP; PLASMID; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SLEEP DISORDER; SPLEEN; SPLEEN WEIGHT; SUICIDAL IDEATION; WEIGHT CHANGE; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BRAIN TUMOR; C57BL MOUSE; CONDITIONED REFLEX; ENCEPHALITIS; FEAR; ILLNESS BEHAVIOR; METABOLISM; NECROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN NEOPLASMS; CONDITIONING, CLASSICAL; DEPRESSION; ENCEPHALITIS; FEAR; ILLNESS BEHAVIOR; MALE; MEMORY; MICE, INBRED C57BL; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84995459599     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.08.001     Document Type: Article

References (82)

1. Acharjee, S., Nayani, N., Tsutsui, M., Hill, M.N., Ousman, S.S., Pittman, Q.J., Altered cognitive-emotional behavior in early experimental autoimmune encephalitis – Cytokine and hormonal correlates. Brain Behav. Immun. 33 (2013), 164–172.
2. Ameloot, P., Fiers, W., Bleser, P.D., Ware, C.F., Vandenabeele, P., Brouckaert, P., Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. J. Biol. Chem. 276 (2001), 37426–37430.
3. American Psychiatric Association, Diagnostical and Statistical Manual of Mental Disorders: DSM-V-TR. fifth ed., 2013, American Psychiatric Association, Washington, DC.
4. Aschauer, D.F., Kreuz, S., Rumpel, S., Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS One, 8, 2013, e76310.
5. Aubert, A., Dantzer, R., The taste of sickness: lipopolysaccharide-induced finickiness in rats. Physiol. Behav. 84 (2005), 437–444.
6. Azzinnari, D., Sigrist, H., Staehli, S., Palme, R., Hildebrandt, T., Leparc, G., Hengerer, B., Seifritz, E., Pryce, C.R., Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function. Neuropharmacology 85 (2014), 328–341.
7. Baens, M., Noels, H., Broeckx, V., Hagens, S., Fevery, S., Billiau, A.D., Vankelecom, H., Marynen, P., The Dark Side of EGFP: defective polyubiquitination. PLoS One, 1, 2006, e54.
8. Banks, W.A., Plotkin, S.R., Kastin, A.J., Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation 2 (1995), 161–165.
9. Bannerman, D.M., Sprengel, R., Sanderson, D.J., McHugh, S.B., Rawlins, J.N.P., Monyer, H., Seeburg, P.H., Hippocampal synaptic plasticity, spatial memory and anxiety. Nat. Rev. Neurosci. 15 (2014), 181–192.
10. Bergamini, G., Cathomas, F., Auer, S., Sigrist, H., Seifritz, E., Patterson, M., Gabriel, C., Pryce, C.R., et al. Mouse psychosocial stress reduces motivation and cognitive function in operant reward tests: a model for reward pathology with effects of agomelatine. Eur. Neuropsychopharmacol., 2016, 10.1016/j.euroneuro.2016.06.009 [Epub ahead of print].
11. Bette, M., Kaut, O., Schäfer, M.K.-H., Weihe, E., Constitutive expression of p55TNFR mRNA and mitogen-specific up-regulation of TNFα and p75TNFR mRNA in mouse brain. J. Comp. Neurol. 465 (2003), 417–430.
12. Biesmans, S., Meert, T.F., Bouwknecht, J.A., Acton, P.D., Davoodi, N., De Haes, P., Kuijlaars, J., Langlois, X., Matthews, L.J.R., Ver Donck, L., et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice, systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflammation, 2013(2013), 2013, e271359.
13. Bluthé, R.M., Pawlowski, M., Suarez, S., Parnet, P., Pittman, Q., Kelley, K.W., Dantzer, R., Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19 (1994), 197–207.
14. Bluthé, R.-M., Michaud, B., Poli, V., Dantzer, R., Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 70 (2000), 367–373.
15. Britt, J.P., Benaliouad, F., McDevitt, R.A., Stuber, G.D., Wise, R.A., Bonci, A., Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 76 (2012), 790–803.
16. Brouckaert, P.G.G., Leroux-Roels, G.G., Guisez, Y., Tavernier, J., Fiers, W., In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma. Int. J. Cancer 38 (1986), 763–769.
17. Cathomas, F., Stegen, M., Sigrist, H., Schmid, L., Seifritz, E., Gassmann, M., Bettler, B., Pryce, C.R., Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Transl. Psychiatry, 5, 2015, e510.
18. Cathomas, F., Fuertig, R., Sigrist, H., Newman, G.N., Hoop, V., Bizzozzero, M., Mueller, A., Luippold, A., Ceci, A., Hengerer, B., et al. CD40-TNF activation in mice induces extended sickness behavior syndrome co-incident with but not dependent on activation of the kynurenine pathway. Brain Behav. Immun. 50 (2015), 125–140.
19. Cavadini, G., Petrzilka, S., Kohler, P., Jud, C., Tobler, I., Birchler, T., Fontana, A., TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. 104 (2007), 12843–12848.
20. Cuthbert, B.N., Insel, T.R., Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med., 11, 2013, 126.
21. Dantzer, R., Kelley, K.W., Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21 (2007), 153–160.
22. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56.
23. Dean, B., Tawadros, N., Scarr, E., Gibbons, A.S., Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J. Affect. Disord. 120 (2010), 245–248.
24. Der-Avakian, A., Markou, A., The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 35 (2012), 68–77.
25. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctôt, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67 (2010), 446–457.
26. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., Calos, M.P., Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7 (1987), 379–387.
27. Duvarci, S., Pare, D., Amygdala microcircuits controlling learned fear. Neuron 82 (2014), 966–980.
28. Erickson, M.A., Banks, W.A., Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav. Immun. 25 (2011), 1637–1648.
29. Frenois, F., Moreau, M., O'Connor, J., Lawson, M., Micon, C., Lestage, J., Kelley, K.W., Dantzer, R., Castanon, N., Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32 (2007), 516–531.
30. Fu, H., Muenzer, J., Samulski, R.J., Breese, G., Sifford, J., Zeng, X., McCarty, D.M., Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol. Ther. 8 (2003), 911–917.
31. Fuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., et al. Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: both effects are reversed by inhibition of indoleamine 2,3-dioxygenase. Brain Behav. Immun. 54 (2016), 59–72.
32. Gao, G.-P., Alvira, M.R., Wang, L., Calcedo, R., Johnston, J., Wilson, J.M., Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. 99 (2002), 11854–11859.
33. Gast, H., Müller, A., Lopez, M., Meier, D., Huber, R., Dechent, F., Prinz, M., Emmenegger, Y., Franken, P., Birchler, T., et al. CD40 activation induces NREM sleep and modulates genes associated with sleep homeostasis. Brain Behav. Immun. 27 (2013), 133–144.
34. Graham, F.L., Smiley, J., Russell, W.C., Nairn, R., Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1977), 59–74.
35. Habbas, S., Santello, M., Becker, D., Stubbe, H., Zappia, G., Liaudet, N., Klaus, F.R., Kollias, G., Fontana, A., Pryce, C.R., et al. Neuroinflammatory TNFα impairs memory via astrocyte signaling. Cell 163 (2015), 1730–1741.
36. Haji, N., Mandolesi, G., Gentile, A., Sacchetti, L., Fresegna, D., Rossi, S., Musella, A., Sepman, H., Motta, C., Studer, V., et al. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp. Neurol. 237 (2012), 296–303.
37. van Heesch, F., Prins, J., Korte-Bouws, G.A.H., Westphal, K.G.C., Lemstra, S., Olivier, B., Kraneveld, A.D., Korte, S.M., Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice. Behav. Brain Res. 253 (2013), 191–195.
38. Howard, D.B., Powers, K., Wang, Y., Harvey, B.K., Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372 (2008), 24–34.
39. Jing, H., Hao, Y., Bi, Q., Zhang, J., Yang, P., Intra-amygdala microinjection of TNF-α impairs the auditory fear conditioning of rats via glutamate toxicity. Neurosci. Res. 91 (2015), 34–40.
40. Johansen, J.P., Cain, C.K., Ostroff, L.E., LeDoux, J.E., Molecular mechanisms of fear learning and memory. Cell 147 (2011), 509–524.
41. Kammula, U.S., White, D.E., Rosenberg, S.A., Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. Cancer 83 (1998), 797–805.
42. Kaster, M.P., Gadotti, V.M., Calixto, J.B., Santos, A.R.S., Rodrigues, A.L.S., Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 62 (2012), 419–426.
43. Kim, J.J., Rison, R.A., Fanselow, M.S., Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 107 (1993), 1093–1098.
44. Kim, E.J., Horovitz, O., Pellman, B.A., Tan, L.M., Li, Q., Richter-Levin, G., Kim, J.J., Dorsal periaqueductal gray-amygdala pathway conveys both innate and learned fear responses in rats. Proc. Natl. Acad. Sci. USA 110 (2013), 14795–14800.
45. Kinsey, S.G., Bailey, M.T., Sheridan, J.F., Padgett, D.A., The inflammatory response to social defeat is increased in older mice. Physiol. Behav. 93 (2008), 628–636.
46. Kuprash, D.V., Udalova, I.A., Turetskaya, R.L., Kwiatkowski, D., Rice, N.R., Nedospasov, S.A., Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol. 162 (1999), 4045–4052.
47. Lawson, M.A., McCusker, R.H., Kelley, K.W., Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J. Neuroinflammation, 10, 2013, 54.
48. Maes, M., Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995), 11–38.
49. Maren, S., Phan, K.L., Liberzon, I., The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat. Rev. Neurosci. 14 (2013), 417–428.
50. Marques-Vidal, P., Bochud, M., Bastardot, F., Lüscher, T., Ferrero, F., Gaspoz, J.-M., Paccaud, F., Urwyler, A., von Känel, R., Hock, C., et al. Levels and Determinants of Inflammatory Biomarkers in a Swiss Population-Based Sample (CoLaus Study). PLoS One, 6, 2011.
51. McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P.A., Hirschhorn, J.N., Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9 (2008), 356–369.
52. McCarty, D.M., Monahan, P.E., Samulski, R.J., Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8 (2001), 1248–1254.
53. McCarty, D.M., Fu, H., Monahan, P.E., Toulson, C.E., Naik, P., Samulski, R.J., Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10 (2003), 2112–2118.
54. McNaughton, N., Gray, J.A., Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J. Affect. Disord. 61 (2000), 161–176.
55. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (2009), 732–741.
56. Mössner, R., Mikova, O., Koutsilieri, E., Saoud, M., Ehlis, A.-C., Müller, N., Fallgatter, A.J., Riederer, P.D.P., Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World J. Biol. Psychiatry 8 (2007), 141–174.
57. Murray, C.J.L., Lopez, A.D., Evidence-based health policy–lessons from the global burden of disease study. Science 274 (1996), 740–743.
58. Nadeau, S., Rivest, S., Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood–brain barrier. Neuroscience 93 (1999), 1449–1464.
59. Orsini, C.A., Maren, S., Neural and cellular mechanisms of fear and extinction memory formation. Neurosci. Biobehav. Rev. 36 (2012), 1773–1802.
60. Palin, K., Bluthé, R.-M., McCusker, R.H., Moos, F., Dantzer, R., Kelley, K.W., TNFα-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I. J. Neuroimmunol. 187 (2007), 55–60.
61. Palin, K., Bluthé, R.-M., McCusker, R.H., Levade, T., Moos, F., Dantzer, R., Kelley, K.W., The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFα-induced sickness behavior. Psychopharmacology 201 (2009), 549–556.
62. Paterna, J.C., Moccetti, T., Mura, A., Feldon, J., Büeler, H., Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 7 (2000), 1304–1311.
63. Paterna, J.-C., Feldon, J., Büeler, H., Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J. Virol. 78 (2004), 6808–6817.
64. Paxinos, G., Franklin, K.B.J., The Mouse Brain in Stereotaxic Coordinates. 2008, Gulf Professional Publishing.
65. Phelps, E.A., LeDoux, J.E., Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48 (2005), 175–187.
66. Pryce, C.R., Fontana, A., Depression in autoimmune diseases. Curr. Top. Behav. Neurosci., 2016 (in press).
67. Pryce, C.R., Azzinnari, D., Sigrist, H., Gschwind, T., Lesch, K.-P., Seifritz, E., Establishing a learned-helplessness effect paradigm in C57BL/6 mice: behavioural evidence for emotional, motivational and cognitive effects of aversive uncontrollability per se. Neuropharmacology 62 (2012), 358–372.
68. Pugh, C.R., Kumagawa, K., Fleshner, M., Watkins, L.R., Maier, S.F., Rudy, J.W., Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 12 (1998), 212–229.
69. Qin, L., Wu, X., Block, M.L., Liu, Y., Breese, G.R., Hong, J.-S., Knapp, D.J., Crews, F.T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007), 453–462.
70. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
71. Salazar, A., Gonzalez-Rivera, B.L., Redus, L., Parrott, J.M., O'Connor, J.C., Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm. Behav. 62 (2012), 202–209.
72. Silverman, M.N., Macdougall, M.G., Hu, F., Pace, T.W.W., Raison, C.L., Miller, A.H., Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally infected mice. Mol. Psychiatry 12 (2007), 408–417.
73. Smith, R.S., The macrophage theory of depression. Med. Hypotheses 35 (1991), 298–306.
74. Thomson, L.M., Sutherland, R.J., Systemic administration of lipopolysaccharide and interleukin-1β have different effects on memory consolidation. Brain Res. Bull. 67 (2005), 24–29.
75. Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., Krishnan, R., Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006), 29–35.
76. Ueno, M., Akiguchi, I., Hosokawa, M., Kotani, H., Kanenishi, K., Sakamoto, H., Blood-brain barrier permeability in the periventricular areas of the normal mouse brain. Acta Neuropathol. (Berl.) 99 (2000), 385–392.
77. Wang, C., Wang, C.-M., Clark, K.R., Sferra, T.J., Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Ther. 10 (2003), 1528–1534.
78. Warden, D., Rush, A.J., Trivedi, M.H., Fava, M., Wisniewski, S.R., The STAR*D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9 (2007), 449–459.
79. Willner, P., Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134 (1997), 319–329.
80. Wohleb, E.S., Powell, N.D., Godbout, J.P., Sheridan, J.F., Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33 (2013), 13820–13833.
81. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992, World Health Organization, Geneva.
82. Zolotukhin, S., Byrne, B.J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R.J., Muzyczka, N., Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6 (1999), 973–985.